Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 25 to 36 of 55 entries
Sorted by: Best Match Show Resources per page
Past year use or misuse of an opioid is associated with use of a sedative-hypnotic medication: a NSDUH study.

Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine

Tubbs AS, Ghani SB, Naps M, Grandner MA, Stein MD, Chakravorty S.
PMID: 34666879
J Clin Sleep Med. 2021 Oct 20; doi: 10.5664/jcsm.9724. Epub 2021 Oct 20.

STUDY OBJECTIVES: Prescription use and misuse of opioids are linked to greater sleep disturbance. However, there are limited data on the prevalence of sedative-hypnotic medication use among persons who use opioids. Therefore, this study examined whether past year sedative-hypnotic...

Cite
Tubbs AS, Ghani SB, Naps M, et al. Past year use or misuse of an opioid is associated with use of a sedative-hypnotic medication: a NSDUH study. J Clin Sleep Med. 2021;doi: 10.5664/jcsm.9724.
Tubbs, A. S., Ghani, S. B., Naps, M., Grandner, M. A., Stein, M. D., & Chakravorty, S. (2021). Past year use or misuse of an opioid is associated with use of a sedative-hypnotic medication: a NSDUH study. Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine, . https://doi.org/10.5664/jcsm.9724
Tubbs, Andrew S, et al. "Past year use or misuse of an opioid is associated with use of a sedative-hypnotic medication: a NSDUH study." Journal of clinical sleep medicine : JCSM : official publication of the American Academy of Sleep Medicine vol. (2021). doi: https://doi.org/10.5664/jcsm.9724
Tubbs AS, Ghani SB, Naps M, Grandner MA, Stein MD, Chakravorty S. Past year use or misuse of an opioid is associated with use of a sedative-hypnotic medication: a NSDUH study. J Clin Sleep Med. 2021 Oct 20; doi: 10.5664/jcsm.9724. Epub 2021 Oct 20. PMID: 34666879.
Copy Download .nbib Format: NLM
Medication not accounted for in hospital electronic medication administration records: a retrospective observational study.

The Medical journal of Australia

Walker K, Harding AM, Tran J, Wembridge P, Garrett K, MacMillan K, Rofe O, Jones N, Taylor D.
PMID: 34970740
Med J Aust. 2021 Dec 30; doi: 10.5694/mja2.51370. Epub 2021 Dec 30.

OBJECTIVE: To determine the nature, extent, and cost of discrepancies between the quantities of medications supplied to medical departments and administered to patients in public hospitals.DESIGN: Multicentre, retrospective observational study; analysis of electronic pharmacy drug management system (medication supply)...

Cite
Walker K, Harding AM, Tran J, et al. Medication not accounted for in hospital electronic medication administration records: a retrospective observational study. Med J Aust. 2021;doi: 10.5694/mja2.51370.
Walker, K., Harding, A. M., Tran, J., Wembridge, P., Garrett, K., MacMillan, K., Rofe, O., Jones, N., & Taylor, D. (2021). Medication not accounted for in hospital electronic medication administration records: a retrospective observational study. The Medical journal of Australia, . https://doi.org/10.5694/mja2.51370
Walker, Kimberly, et al. "Medication not accounted for in hospital electronic medication administration records: a retrospective observational study." The Medical journal of Australia vol. (2021). doi: https://doi.org/10.5694/mja2.51370
Walker K, Harding AM, Tran J, Wembridge P, Garrett K, MacMillan K, Rofe O, Jones N, Taylor D. Medication not accounted for in hospital electronic medication administration records: a retrospective observational study. Med J Aust. 2021 Dec 30; doi: 10.5694/mja2.51370. Epub 2021 Dec 30. PMID: 34970740.
Copy Download .nbib Format: NLM
Proton pump inhibitors associated with rapid eye movement sleep behaviour disorder.

BMJ case reports

Jayasekara R, Smith I.
PMID: 34972777
BMJ Case Rep. 2021 Dec 31;14(12). doi: 10.1136/bcr-2021-246469.

We present the case of a 65-year-old woman diagnosed with rapid eye movement sleep behaviour disorder (REMBD) based on typical symptoms and confirmed with an inpatient polysomnogram. She was prescribed clonazepam and later temazepam but continued to have intrusive...

Cite
Jayasekara R, Smith I. Proton pump inhibitors associated with rapid eye movement sleep behaviour disorder. BMJ Case Rep. 2021;14(12)doi: 10.1136/bcr-2021-246469.
Jayasekara, R., & Smith, I. (2021). Proton pump inhibitors associated with rapid eye movement sleep behaviour disorder. BMJ case reports, 14(12), . https://doi.org/10.1136/bcr-2021-246469
Jayasekara, Ruwanthi, and Smith, Ian. "Proton pump inhibitors associated with rapid eye movement sleep behaviour disorder." BMJ case reports vol. 14,12 (2021). doi: https://doi.org/10.1136/bcr-2021-246469
Jayasekara R, Smith I. Proton pump inhibitors associated with rapid eye movement sleep behaviour disorder. BMJ Case Rep. 2021 Dec 31;14(12). doi: 10.1136/bcr-2021-246469. PMID: 34972777.
Copy Download .nbib Format: NLM
Rhabdomyolysis in Clozapine Overdose.

Drug safety - case reports

Jansman FG, Crommelin HA, van Hout FJ, Meulenbelt J.
PMID: 27747721
Drug Saf Case Rep. 2015 Dec;2(1):9. doi: 10.1007/s40800-015-0011-7.

CONTEXT: Clozapine is used for decennia for the treatment of schizophrenia. Agranulocytosis, diabetic ketoacidosis, gastrointestinal hypomotility, and myocarditis are well-known adverse effects of clozapine, which are sometimes life threatening. Here we report a case of rhabdomyolysis upon an acute...

Cite
Jansman FG, Crommelin HA, van Hout FJ, et al. Rhabdomyolysis in Clozapine Overdose. Drug Saf Case Rep. 2015;2(1):9doi: 10.1007/s40800-015-0011-7.
Jansman, F. G., Crommelin, H. A., van Hout, F. J., & Meulenbelt, J. (2015). Rhabdomyolysis in Clozapine Overdose. Drug safety - case reports, 2(1), 9. https://doi.org/10.1007/s40800-015-0011-7
Jansman, Frank G A, et al. "Rhabdomyolysis in Clozapine Overdose." Drug safety - case reports vol. 2,1 (2015): 9. doi: https://doi.org/10.1007/s40800-015-0011-7
Jansman FG, Crommelin HA, van Hout FJ, Meulenbelt J. Rhabdomyolysis in Clozapine Overdose. Drug Saf Case Rep. 2015 Dec;2(1):9. doi: 10.1007/s40800-015-0011-7. PMID: 27747721; PMCID: PMC5005766.
Copy Download .nbib Format: NLM
Proton pump inhibitors associated with rapid eye movement sleep behaviour disorder.

BMJ case reports

Jayasekara R, Smith I.
PMID: 34972777
BMJ Case Rep. 2021 Dec 31;14(12). doi: 10.1136/bcr-2021-246469.

We present the case of a 65-year-old woman diagnosed with rapid eye movement sleep behaviour disorder (REMBD) based on typical symptoms and confirmed with an inpatient polysomnogram. She was prescribed clonazepam and later temazepam but continued to have intrusive...

Cite
Jayasekara R, Smith I. Proton pump inhibitors associated with rapid eye movement sleep behaviour disorder. BMJ Case Rep. 2021;14(12)doi: 10.1136/bcr-2021-246469.
Jayasekara, R., & Smith, I. (2021). Proton pump inhibitors associated with rapid eye movement sleep behaviour disorder. BMJ case reports, 14(12), . https://doi.org/10.1136/bcr-2021-246469
Jayasekara, Ruwanthi, and Smith, Ian. "Proton pump inhibitors associated with rapid eye movement sleep behaviour disorder." BMJ case reports vol. 14,12 (2021). doi: https://doi.org/10.1136/bcr-2021-246469
Jayasekara R, Smith I. Proton pump inhibitors associated with rapid eye movement sleep behaviour disorder. BMJ Case Rep. 2021 Dec 31;14(12). doi: 10.1136/bcr-2021-246469. PMID: 34972777.
Copy Download .nbib Format: NLM
Fatigue in Aviation: Safety Risks, Preventive Strategies and Pharmacological Interventions.

Frontiers in physiology

Wingelaar-Jagt YQ, Wingelaar TT, Riedel WJ, Ramaekers JG.
PMID: 34552504
Front Physiol. 2021 Sep 06;12:712628. doi: 10.3389/fphys.2021.712628. eCollection 2021.

Fatigue poses an important safety risk to civil and military aviation. In addition to decreasing performance in-flight (chronic) fatigue has negative long-term health effects. Possible causes of fatigue include sleep loss, extended time awake, circadian phase irregularities and work...

Cite
Wingelaar-Jagt YQ, Wingelaar TT, Riedel WJ, et al. Fatigue in Aviation: Safety Risks, Preventive Strategies and Pharmacological Interventions. Front Physiol. 2021;12:712628doi: 10.3389/fphys.2021.712628.
Wingelaar-Jagt, Y. Q., Wingelaar, T. T., Riedel, W. J., & Ramaekers, J. G. (2021). Fatigue in Aviation: Safety Risks, Preventive Strategies and Pharmacological Interventions. Frontiers in physiology, 12712628. https://doi.org/10.3389/fphys.2021.712628
Wingelaar-Jagt, Yara Q, et al. "Fatigue in Aviation: Safety Risks, Preventive Strategies and Pharmacological Interventions." Frontiers in physiology vol. 12 (2021): 712628. doi: https://doi.org/10.3389/fphys.2021.712628
Wingelaar-Jagt YQ, Wingelaar TT, Riedel WJ, Ramaekers JG. Fatigue in Aviation: Safety Risks, Preventive Strategies and Pharmacological Interventions. Front Physiol. 2021 Sep 06;12:712628. doi: 10.3389/fphys.2021.712628. eCollection 2021. PMID: 34552504; PMCID: PMC8451537.
Copy Download .nbib Format: NLM
Repeat prescribing: which diagnoses, which drugs?.

Pharmacoepidemiology and drug safety

Connolly JP, McGavock H.
PMID: 19025833
Pharmacoepidemiol Drug Saf. 2000 Jul;9(4):305-11. doi: 10.1002/1099-1557(200007/08)9:4<305::AID-PDS513>3.0.CO;2-O.

Background-Repeat prescribing should be limited to drugs which are to be prescribed on a long-term basis to patients whose conditions are stable. Early studies were based on small sample sizes. The definition of repeat prescribing has not been consistent...

Cite
Connolly JP, McGavock H. Repeat prescribing: which diagnoses, which drugs?. Pharmacoepidemiol Drug Saf. 2000;9(4):305-11doi: 10.1002/1099-1557(200007/08)9:4<305::AID-PDS513>3.0.CO;2-O.
Connolly, J. P., & McGavock, H. (2000). Repeat prescribing: which diagnoses, which drugs?. Pharmacoepidemiology and drug safety, 9(4), 305-11. https://doi.org/10.1002/1099-1557(200007/08)9:4<305::AID-PDS513>3.0.CO;2-O
Connolly, J P, and McGavock, H. "Repeat prescribing: which diagnoses, which drugs?." Pharmacoepidemiology and drug safety vol. 9,4 (2000): 305-11. doi: https://doi.org/10.1002/1099-1557(200007/08)9:4<305::AID-PDS513>3.0.CO;2-O
Connolly JP, McGavock H. Repeat prescribing: which diagnoses, which drugs?. Pharmacoepidemiol Drug Saf. 2000 Jul;9(4):305-11. doi: 10.1002/1099-1557(200007/08)9:4<305::AID-PDS513>3.0.CO;2-O. PMID: 19025833.
Copy Download .nbib Format: NLM
Mass Spectra and Cross-Contribution of Ion Intensity Between Drug Analytes and Their Isotopically Labelled Analogs - Benzodiazepines and Their Derivatives.

Forensic science review

Wang SM, Chen BG, Wu MY, Liu RH, Lewis RJ, Ritter RM, Canfield DV.
PMID: 26242324
Forensic Sci Rev. 2009 Jul;21(2):69-144.

With GC-MS as the preferred method and isotopically labeled analogs (ILAs) of the analytes as the internal standards (ISs) of choice for quantitative determination of drugs/metabolites in biological specimens, one important aspect associated with chemical derivatization (CD) is that...

Cite
Wang SM, Chen BG, Wu MY, et al. Mass Spectra and Cross-Contribution of Ion Intensity Between Drug Analytes and Their Isotopically Labelled Analogs - Benzodiazepines and Their Derivatives. Forensic Sci Rev. 2009;21(2):69-144
Wang, S. M., Chen, B. G., Wu, M. Y., Liu, R. H., Lewis, R. J., Ritter, R. M., & Canfield, D. V. (2009). Mass Spectra and Cross-Contribution of Ion Intensity Between Drug Analytes and Their Isotopically Labelled Analogs - Benzodiazepines and Their Derivatives. Forensic science review, 21(2), 69-144.
Wang, S M, et al. "Mass Spectra and Cross-Contribution of Ion Intensity Between Drug Analytes and Their Isotopically Labelled Analogs - Benzodiazepines and Their Derivatives." Forensic science review vol. 21,2 (2009): 69-144.
Wang SM, Chen BG, Wu MY, Liu RH, Lewis RJ, Ritter RM, Canfield DV. Mass Spectra and Cross-Contribution of Ion Intensity Between Drug Analytes and Their Isotopically Labelled Analogs - Benzodiazepines and Their Derivatives. Forensic Sci Rev. 2009 Jul;21(2):69-144. PMID: 26242324.
Copy Download .nbib Format: NLM
HPLC analysis and pharmacokinetics of the enantiomers of R,S-oxazepam and R,S-temazepam with their corresponding glucuronide conjugates in urine and plasma of man.

Acta neuropsychiatrica

Vree TB, Baars AM, Wuis EW.
PMID: 26952555
Acta Neuropsychiatr. 1990 Dec;2(4):95-100. doi: 10.1017/S0924270800034505.

R,S-Oxazepam and R,S-temazepam can be separated in their enantiomers by means of a chiral AGP column. The corresponding R- and S-glucuronide conjugates can be separated on a normal reversed-phase C18 column. Man conjugates the S-enantiomer of oxazepam and temazepam...

Cite
Vree TB, Baars AM, Wuis EW. HPLC analysis and pharmacokinetics of the enantiomers of R,S-oxazepam and R,S-temazepam with their corresponding glucuronide conjugates in urine and plasma of man. Acta Neuropsychiatr. 1990;2(4):95-100doi: 10.1017/S0924270800034505.
Vree, T. B., Baars, A. M., & Wuis, E. W. (1990). HPLC analysis and pharmacokinetics of the enantiomers of R,S-oxazepam and R,S-temazepam with their corresponding glucuronide conjugates in urine and plasma of man. Acta neuropsychiatrica, 2(4), 95-100. https://doi.org/10.1017/S0924270800034505
Vree, T B, et al. "HPLC analysis and pharmacokinetics of the enantiomers of R,S-oxazepam and R,S-temazepam with their corresponding glucuronide conjugates in urine and plasma of man." Acta neuropsychiatrica vol. 2,4 (1990): 95-100. doi: https://doi.org/10.1017/S0924270800034505
Vree TB, Baars AM, Wuis EW. HPLC analysis and pharmacokinetics of the enantiomers of R,S-oxazepam and R,S-temazepam with their corresponding glucuronide conjugates in urine and plasma of man. Acta Neuropsychiatr. 1990 Dec;2(4):95-100. doi: 10.1017/S0924270800034505. PMID: 26952555.
Copy Download .nbib Format: NLM
Temazepam misused in spite of new formula.

Nursing standard (Royal College of Nursing (Great Britain) : 1987)

[No authors listed]
PMID: 27680140
Nurs Stand. 1991 Dec 11;6(12):15. doi: 10.7748/ns.6.12.15.s35.

Despite a change in the formulation of the drug temazepam, doctors from Charing Cross Hospital have reported that it continues to be injected by intravenous drug abusers.

Cite
Temazepam misused in spite of new formula. Nurs Stand. 1991;6(12):15doi: 10.7748/ns.6.12.15.s35.
(1991). Temazepam misused in spite of new formula. Nursing standard (Royal College of Nursing (Great Britain) : 1987), 6(12), 15. https://doi.org/10.7748/ns.6.12.15.s35
"Temazepam misused in spite of new formula." Nursing standard (Royal College of Nursing (Great Britain) : 1987) vol. 6,12 (1991): 15. doi: https://doi.org/10.7748/ns.6.12.15.s35
Temazepam misused in spite of new formula. Nurs Stand. 1991 Dec 11;6(12):15. doi: 10.7748/ns.6.12.15.s35. PMID: 27680140.
Copy Download .nbib Format: NLM
Normalizing sleep quality disturbed by psychiatric polypharmacy: a single patient open trial (SPOT).

F1000Research

Magnuson V, Wang Y, Schork N.
PMID: 28781744
F1000Res. 2016 Feb 03;5:132. doi: 10.12688/f1000research.7694.2. eCollection 2016.

There is a growing interest in personalized and preventive medicine initiatives that leverage serious patient engagement, such as those initiated and pursued among participants in the quantified-self movement. However, many of the self-assessments that result are not rooted in...

Cite
Magnuson V, Wang Y, Schork N. Normalizing sleep quality disturbed by psychiatric polypharmacy: a single patient open trial (SPOT). F1000Res. 2016;5:132doi: 10.12688/f1000research.7694.2.
Magnuson, V., Wang, Y., & Schork, N. (2016). Normalizing sleep quality disturbed by psychiatric polypharmacy: a single patient open trial (SPOT). F1000Research, 5132. https://doi.org/10.12688/f1000research.7694.2
Magnuson, Victoria, et al. "Normalizing sleep quality disturbed by psychiatric polypharmacy: a single patient open trial (SPOT)." F1000Research vol. 5 (2016): 132. doi: https://doi.org/10.12688/f1000research.7694.2
Magnuson V, Wang Y, Schork N. Normalizing sleep quality disturbed by psychiatric polypharmacy: a single patient open trial (SPOT). F1000Res. 2016 Feb 03;5:132. doi: 10.12688/f1000research.7694.2. eCollection 2016. PMID: 28781744; PMCID: PMC5527988.
Copy Download .nbib Format: NLM
Contamination profiles, mass loadings, and sewage epidemiology of neuropsychiatric and illicit drugs in wastewater and river waters from a community in the Midwestern United States.

The Science of the total environment

Skees AJ, Foppe KS, Loganathan B, Subedi B.
PMID: 29727969
Sci Total Environ. 2018 Aug 01;631:1457-1464. doi: 10.1016/j.scitotenv.2018.03.060. Epub 2018 Mar 28.

In this study, residues of the neuropsychiatric and illicit drugs including stimulants, opioids, hallucinogens, antischizophrenics, sedatives, and antidepressants were determined in influent and effluent samples from a small wastewater treatment plant, a receiving creek, and river waters in the...

Cite
Skees AJ, Foppe KS, Loganathan B, et al. Contamination profiles, mass loadings, and sewage epidemiology of neuropsychiatric and illicit drugs in wastewater and river waters from a community in the Midwestern United States. Sci Total Environ. 2018;631:1457-1464doi: 10.1016/j.scitotenv.2018.03.060.
Skees, A. J., Foppe, K. S., Loganathan, B., & Subedi, B. (2018). Contamination profiles, mass loadings, and sewage epidemiology of neuropsychiatric and illicit drugs in wastewater and river waters from a community in the Midwestern United States. The Science of the total environment, 6311457-1464. https://doi.org/10.1016/j.scitotenv.2018.03.060
Skees, Allie J, et al. "Contamination profiles, mass loadings, and sewage epidemiology of neuropsychiatric and illicit drugs in wastewater and river waters from a community in the Midwestern United States." The Science of the total environment vol. 631 (2018): 1457-1464. doi: https://doi.org/10.1016/j.scitotenv.2018.03.060
Skees AJ, Foppe KS, Loganathan B, Subedi B. Contamination profiles, mass loadings, and sewage epidemiology of neuropsychiatric and illicit drugs in wastewater and river waters from a community in the Midwestern United States. Sci Total Environ. 2018 Aug 01;631:1457-1464. doi: 10.1016/j.scitotenv.2018.03.060. Epub 2018 Mar 28. PMID: 29727969; PMCID: PMC8003212.
Copy Download .nbib Format: NLM
Showing 25 to 36 of 55 entries